Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on June 25, 2026

Ureteral Stents Market to reach USD 1,259.9 Million by 2035 at 6.55% CAGR
Medical Radiation Shielding Market to reach USD 3.39 Billion by 2035 at 7.1% CAGR
Genetic Toxicology Testing Market to reach USD 886.14 Million by 2035 at 8.75% CAGR
Insulin Syringes Market to reach USD 3.00 Billion by 2035 at 4.70% CAGR
Cell Cryopreservation Market to reach USD 90.92 Billion by 2035 at 19.8% CAGR
Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
Atalan Launches Nurse Retention Platform Designed to Identify Risk Up to 12 Months in Advance
Lab52 n-HAP Kids Toothpaste Named “Toothpaste Product of the Year” In 2026 Baby Innovation Awards
Data Presented on Two-Year Proximal Neck Dynamics from First-in-Human Study of Abdominal Aortic Aneurysm Treatment
Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)
Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
TRUE-See Selected to Participate in Microsoft for Start-Ups Azure AI Program to Accelerate Innovation and Growth
Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Observer Falkland Islands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.